ClinicalTrials.Veeva
Menu

Find clinical trials for Endometrial Cancer in Cleveland, OH

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Carcinoma
Cancer
Ovarian Cancer
Breast Cancer
Ovarian Epithelial Carcinoma
Triple Negative Breast Cancer
Adenocarcinoma

Endometrial Cancer trials near Cleveland, OH, USA:

Durvalumab With or Without Olaparib as Maintenance Therapy After First-Line Treatment of Advanced and Recurrent Endometrial Cancer (DUO-E)

(paclitaxel + carboplatin) followed by maintenance durvalumab with or without olaparib for patients with newly diagnosed advanced or recurrent endometrial...

Active, not recruiting
Endometrial Neoplasms
Drug: Carboplatin
Biological: durvalumab

Phase 3

AstraZeneca
AstraZeneca

Cleveland, Ohio, United States and 202 other locations

participants with recurrent or primary advanced (Stage III or IV) endometrial cancer....

Active, not recruiting
Neoplasms
Drug: Carboplatin
Drug: Paclitaxel

Phase 3

Tesaro
Tesaro

Cleveland, Ohio, United States and 162 other locations

compared to Tamoxifen and Medroxyprogesterone acetate in treating endometrial cancer and to determine the types and severity of sid...

Active, not recruiting
Advanced, Persistent, or Recurrent Endometrial Cancer
Drug: Medroxyprogesterone Acetate
Drug: Tamoxifen

Phase 2

GOG Foundation

Cleveland, Ohio, United States and 25 other locations

This study, ELU- FRα-1, is focused on adult subjects who have advanced, recurrent or refractory folate receptor alpha (FRα) overexpressing tumors con...

Active, not recruiting
Ovarian Cancer Stage
Fallopian Tube Cancer
Drug: ELU001

Phase 1, Phase 2

Elucida Oncology

Cleveland, Ohio, United States and 16 other locations

This is a Phase 1 open label sequential dose escalation and cohort expansion study evaluating the safety, tolerability and preliminary clinical activ...

Active, not recruiting
Endometrial Cancer
Advanced Cancer
Drug: COM701 with Opdivo (Nivolumab).
Drug: COM701

Phase 1

Compugen

Cleveland, Ohio, United States and 10 other locations

The goal of this clinical trial is to evaluate the safety of TOS-358 in adults with select solid tumors who meet study enrollment criteria. The main...

Enrolling
Endometrial Cancer
Gastric Cancer
Drug: TOS-358

Phase 1

Totus Medicines

Cleveland, Ohio, United States and 15 other locations

in participants with platinum-resistant ovarian carcinoma, endometrial adenocarcinoma, and urothelial carcinoma based on Acrivon's OncoSigna...

Enrolling
Endometrial Adenocarcinoma
Platinum-resistant Ovarian Cancer
Drug: ACR-368
Diagnostic Test: OncoSignature

Phase 1, Phase 2

Acrivon Therapeutics

Cleveland, Ohio, United States and 67 other locations

first-in-human study will evaluate the safety, tolerability, pharmacokinetics, and antitumor activity of TORL-1-23 in patients with advanced cancer...

Enrolling
Endometrial Cancer
Ovarian Cancer
Drug: TORL-1-23

Phase 1

TORL Biotherapeutics

Cleveland, Ohio, United States and 3 other locations

The purpose of this study is to further evaluate the efficacy and safety of niraparib in patients with locally advanced or metastatic solid tumors an...

Active, not recruiting
Esophageal Cancer
Urologic Cancer
Drug: Niraparib

Phase 2

Tempus AI
Tempus AI

Cleveland, Ohio, United States and 79 other locations

-small-cell lung cancer (NSCLC), triple negative breast cancer (TNBC), ovarian cancer (OC), endometrial cancer...

Active, not recruiting
Castration-resistant Prostate Cancer
Lower Esophageal Cancer
Drug: cabozantinib
Drug: atezolizumab

Phase 1, Phase 2

Exelixis
Exelixis

Cleveland, Ohio, United States and 123 other locations

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems